HAEMONETICS CORP Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Haemonetics Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2011 to Q1 2024.
  • Haemonetics Corp Deferred Tax Assets, Valuation Allowance for the quarter ending March 30, 2024 was $10.2M, a 15.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $10.2M +$1.4M +15.9% Mar 30, 2024 10-K 2024-05-20
Q1 2023 $8.84M -$5.24M -37.2% Apr 1, 2023 10-K 2024-05-20
Q1 2022 $14.1M +$3M +27% Apr 2, 2022 10-K 2023-05-22
Q1 2021 $11.1M -$3.51M -24% Apr 3, 2021 10-K 2022-05-25
Q1 2020 $14.6M +$3.27M +28.8% Mar 28, 2020 10-K 2021-05-26
Q1 2019 $11.3M +$232K +2.09% Mar 30, 2019 10-K 2020-05-20
Q1 2018 $11.1M -$14.8M -57.1% Mar 31, 2018 10-K 2019-05-22
Q1 2017 $25.9M +$1.58M +6.48% Apr 1, 2017 10-K 2018-05-23
Q1 2016 $24.3M +$8.27M +51.6% Apr 2, 2016 10-K 2017-05-24
Q1 2015 $16M +$12.9M +420% Mar 28, 2015 10-K 2016-06-01
Q1 2014 $3.08M +$2.07M +206% Mar 29, 2014 10-K 2015-05-22
Q1 2013 $1.01M -$560K -35.7% Mar 30, 2013 10-K 2014-05-22
Q1 2012 $1.57M -$2.06M -56.8% Mar 31, 2012 10-K 2013-05-20
Q1 2011 $3.63M Apr 2, 2011 10-K 2012-05-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.